diabetes test News
-
Epinex Diagnostics Enters Digital Health Field - Launches `Am I Diabetic` Mobile Phone App
Epinex Diagnostics, Inc., a Tustin, California USA based biomedical company, commemorates National Diabetes Month by launching the “Am I Diabetic” mobile phone app for iPhone and Android devices. The function of this app is to provide educational information and awareness about diabetes. With over half a billion people around the world suffering from diabetes and millions more at ...
-
Getein participated in MEDICA 2018
2018 Medica, world medical fair was held from Nov. 12th to 15th in Dusseldorf, Germany. As a regular exhibitor, this time GP exhibited two series of products. First one is for POC diagnostics. As one of the leading suppliers of POC diagnostics, GP showed portable & smart semi-auto quantitative immunoassay analyzer, as well as fully automatic quantitative immunoassay analyzer, which met the ...
-
Smart Home Lab - a Helpful Alternative to a Physician’s Office
What if the laboratory came home to you? Latest since the corona pandemic, the subject of “selftests” and “rapid tests” has finally reached a broad public. While previously it was more of a topic for chronic patients (e.g. diabetics) or for occasional tests (e.g. pregnancy test), we now see a clear trend. The determination of own body values, disease ...
-
GE Capital provides $35 million credit facility to CCS Medical, Inc.
GE Capital, Healthcare Financial Services today announced it has provided a $35 million revolving line of credit to CCS Medical, Inc. The loan will be used to refinance existing debt, provide working capital and support growth initiatives following CCS Medical’s exit from Chapter 11 bankruptcy protection on March 31, 2010. Founded in 1994, CCS Medical is a leading provider of medical supplies ...
-
Frost & Sullivan Lauds Epinex Diagnostics` Monthly G1A Test as a Superior Alternative to the Existing Diabetes Management Paradigm
Based on its recent analysis of the diabetes point-of-care (POC) diagnostics market, Frost & Sullivan recognizes Epinex Diagnostics with the 2014 Global Frost & Sullivan Award for New Product Innovation. The company's G1A™ rapid test for glycated albumin has initially the potential to bridge the gap between daily self-monitored blood glucose (SMBG) and quarterly glycated hemoglobin ...
-
Digital Diagnostics Partners with Rapidly Scaling Medicare Advantage Organization, ArchWell Health
CORALVILLE, IOWA July 26, 2022 – Digital Diagnostics is proud to announce a partnership with ArchWell Health to bring IDx-DR, the autonomous AI diagnostic system for the detection of diabetic retinopathy (DR) – including diabetic macular edema (DME) – to ArchWell Health centers across the United States. “ArchWell Health is committed to improving patient outcomes and ...
-
Eleven extraordinary women named as inductees to the national women`s hall of fame
The National Women's Hall of Fame today, on International Women's Day, announces the upcoming Induction of eleven American women who have made valuable and enduring contributions to our nation. These women will be formally inducted on September 30th and October 1st, 2011 in Seneca Falls, the birthplace of the American Women's Rights Movement. The National Women's Hall of Fame is the nation's ...
-
Traffic pollution associated with risk of developing type 2 diabetes
Long-term exposure to traffic-related air particle pollution is linked with type 2 diabetes, a new study in Germany has found. Furthermore, the study found that people living close to busy roads were at greater risk of developing the disease than those living further away. Air pollution has been linked to a number of health problems, including heart, circulatory and lung diseases. It has also ...
-
Rutgers researcher invents Microbiota Formula to help high-risk patients fight Covid-19
A Rutgers scientist has invented an early treatment for COVID-19 to prevent severe complications and hospitalizations in patients with prediabetes and diabetes by increasing beneficial bacteria in the gut and reducing organisms that cause coronavirus. The treatment – created by researcher Liping Zhao – was given the Investigational New Drug status by the Food and Drug ...
-
EndoLogic Acquires Renzapride from Alizyme, plc
EndoLogic, a company focused on the development and commercialization of products that treat gastrointestinal diseases, has acquired the worldwide rights to the clinical-stage asset, renzapride, from Alizyme, plc. Renzapride has been in clinical development for use as a prokinetic agent for the gastrointestinal tract. EndoLogic plans on developing the compound for the treatment of gastroparesis. ...
-
POGO Automatic One-Step™ Blood Glucose Monitor Now Available for People with Diabetes in the United States
Intuity Medical, Inc., a commercial-stage medical technology and digital health company focused on making life with diabetes easier, announced today the availability of the POGO Automatic Blood Glucose Monitoring System in the U.S. The product is the first and only FDA-cleared blood glucose monitor whose 10-test cartridge technology makes a glucose test possible with only the press of a button ...
-
New and Encouraging Global Diabetes Market Research Shows People with Diabetes are More Motivated to Manage their Condition than Healthcare Providers May Realize
Key Research Survey Findings: 52 percent of healthcare providers agreed motivation is a major barrier to patients adhering to blood glucose monitoring compared to only 10 percent of people with diabetes who agreed motivation is a major barrier. Healthcare providers claimed they are recommending blood glucose management apps to only 25 percent of their patients, while 55% of patients who ...
By LifeScan
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you